nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—epilepsy syndrome	0.785	1	CbGaD
Mimosine—L-Tyrosine—TH—epilepsy syndrome	0.00287	0.891	CrCbGaD
Mimosine—CCL2—forebrain—epilepsy syndrome	0.00283	0.0973	CbGeAlD
Mimosine—TYR—head—epilepsy syndrome	0.00282	0.097	CbGeAlD
Mimosine—CCL2—telencephalon—epilepsy syndrome	0.0026	0.0895	CbGeAlD
Mimosine—CCL2—medulla oblongata—epilepsy syndrome	0.00205	0.0703	CbGeAlD
Mimosine—CCL2—midbrain—epilepsy syndrome	0.00187	0.0643	CbGeAlD
Mimosine—CCL2—spinal cord—epilepsy syndrome	0.00182	0.0627	CbGeAlD
Mimosine—SHMT1—head—epilepsy syndrome	0.00175	0.0601	CbGeAlD
Mimosine—SHMT1—nervous system—epilepsy syndrome	0.00166	0.057	CbGeAlD
Mimosine—CCL2—head—epilepsy syndrome	0.00162	0.0557	CbGeAlD
Mimosine—SHMT1—central nervous system—epilepsy syndrome	0.0016	0.0549	CbGeAlD
Mimosine—SHMT1—cerebellum—epilepsy syndrome	0.00156	0.0537	CbGeAlD
Mimosine—CCL2—nervous system—epilepsy syndrome	0.00154	0.0528	CbGeAlD
Mimosine—CCL2—central nervous system—epilepsy syndrome	0.00148	0.0509	CbGeAlD
Mimosine—CCL2—cerebellum—epilepsy syndrome	0.00145	0.0497	CbGeAlD
Mimosine—SHMT1—brain—epilepsy syndrome	0.00127	0.0436	CbGeAlD
Mimosine—CCL2—brain—epilepsy syndrome	0.00118	0.0404	CbGeAlD
Mimosine—L-DOPA—CYP2D6—epilepsy syndrome	0.00035	0.109	CrCbGaD
Mimosine—SHMT1—Metabolism—PFKL—epilepsy syndrome	0.000163	0.000892	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—KCNB1—epilepsy syndrome	0.000163	0.000892	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CACNA2D2—epilepsy syndrome	0.000163	0.000892	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLCO1A2—epilepsy syndrome	0.000163	0.000892	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC6A8—epilepsy syndrome	0.000163	0.000892	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—PTGS2—epilepsy syndrome	0.000163	0.000891	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—NPY—epilepsy syndrome	0.000162	0.000887	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—OXT—epilepsy syndrome	0.000157	0.000856	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CRH—epilepsy syndrome	0.000157	0.000856	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000157	0.000856	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL3—epilepsy syndrome	0.000157	0.000856	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM2—epilepsy syndrome	0.000153	0.000836	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL1B—epilepsy syndrome	0.000152	0.000829	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CASP3—epilepsy syndrome	0.000151	0.000827	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—epilepsy syndrome	0.000151	0.000825	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—UPB1—epilepsy syndrome	0.000149	0.000816	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NEU1—epilepsy syndrome	0.000149	0.000816	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ATIC—epilepsy syndrome	0.000149	0.000816	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HSD17B4—epilepsy syndrome	0.000144	0.000785	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MMP9—epilepsy syndrome	0.000143	0.000782	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR2—epilepsy syndrome	0.000142	0.000774	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—SST—epilepsy syndrome	0.000142	0.000774	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000141	0.000771	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—POMC—epilepsy syndrome	0.00014	0.000763	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—TNF—epilepsy syndrome	0.000139	0.000761	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GBE1—epilepsy syndrome	0.000139	0.000758	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPP1R3C—epilepsy syndrome	0.000139	0.000758	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000139	0.000758	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000138	0.000756	CbGpPWpGaD
Mimosine—SHMT1—Disease—ST3GAL3—epilepsy syndrome	0.000138	0.000754	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000136	0.000746	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRDM4—epilepsy syndrome	0.000136	0.000746	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNF—epilepsy syndrome	0.000134	0.000734	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000133	0.000728	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000133	0.000728	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR8—epilepsy syndrome	0.000133	0.000725	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR9—epilepsy syndrome	0.000133	0.000725	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000133	0.000725	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000133	0.000725	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000133	0.000725	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—epilepsy syndrome	0.000132	0.000722	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CNR1—epilepsy syndrome	0.000131	0.000715	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ASAH1—epilepsy syndrome	0.00013	0.000713	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM4—epilepsy syndrome	0.00013	0.000711	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM3—epilepsy syndrome	0.00013	0.000711	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000128	0.000698	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR7—epilepsy syndrome	0.000128	0.000697	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—STXBP1—epilepsy syndrome	0.000127	0.000694	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NT5E—epilepsy syndrome	0.000124	0.000676	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALAD—epilepsy syndrome	0.000124	0.000676	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM8—epilepsy syndrome	0.000123	0.000674	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.00012	0.000655	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ACKR4—epilepsy syndrome	0.000119	0.000652	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CACNA1A—epilepsy syndrome	0.000118	0.000645	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALDH7A1—epilepsy syndrome	0.000118	0.000645	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000118	0.000643	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000118	0.000643	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000117	0.000641	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ST3GAL3—epilepsy syndrome	0.000115	0.000631	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—EIF2S1—epilepsy syndrome	0.000114	0.000624	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ADSL—epilepsy syndrome	0.000113	0.000618	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR7—epilepsy syndrome	0.000113	0.000617	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM1—epilepsy syndrome	0.000113	0.000617	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PDYN—epilepsy syndrome	0.000113	0.000617	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000113	0.000617	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ACTB—epilepsy syndrome	0.000113	0.000617	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000111	0.000608	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GLUL—epilepsy syndrome	0.000111	0.000606	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TNF—epilepsy syndrome	0.00011	0.000602	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CACNA1D—epilepsy syndrome	0.000109	0.000595	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SSTR5—epilepsy syndrome	0.000108	0.00059	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SSTR4—epilepsy syndrome	0.000108	0.00059	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—AVP—epilepsy syndrome	0.000107	0.000587	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GAL—epilepsy syndrome	0.000106	0.00058	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRM5—epilepsy syndrome	0.000105	0.000573	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000105	0.000573	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR10—epilepsy syndrome	0.000103	0.000565	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TXNRD1—epilepsy syndrome	0.000102	0.000557	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000101	0.00055	CbGpPWpGaD
Mimosine—SHMT1—Disease—EIF2AK2—epilepsy syndrome	0.0001	0.000549	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—epilepsy syndrome	0.0001	0.000547	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AQP1—epilepsy syndrome	9.89e-05	0.00054	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CX3CL1—epilepsy syndrome	9.86e-05	0.000539	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—BDKRB1—epilepsy syndrome	9.86e-05	0.000539	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CHRM2—epilepsy syndrome	9.86e-05	0.000539	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—BCHE—epilepsy syndrome	9.71e-05	0.000531	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GABBR1—epilepsy syndrome	9.59e-05	0.000524	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	9.37e-05	0.000512	CbGpPWpGaD
Mimosine—SHMT1—Disease—PPIA—epilepsy syndrome	9.29e-05	0.000508	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRH3—epilepsy syndrome	9.2e-05	0.000503	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR5—epilepsy syndrome	9.13e-05	0.000499	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—OPRM1—epilepsy syndrome	9.05e-05	0.000495	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM2—epilepsy syndrome	9.04e-05	0.000494	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CHRM3—epilepsy syndrome	8.94e-05	0.000489	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—KCNJ11—epilepsy syndrome	8.94e-05	0.000489	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—HTR2A—epilepsy syndrome	8.93e-05	0.000488	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR3—epilepsy syndrome	8.55e-05	0.000467	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—AGT—epilepsy syndrome	8.48e-05	0.000463	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—PLAUR—epilepsy syndrome	8.45e-05	0.000462	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NPY—epilepsy syndrome	8.33e-05	0.000455	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SSTR3—epilepsy syndrome	8.17e-05	0.000447	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CRH—epilepsy syndrome	8.04e-05	0.000439	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL2—epilepsy syndrome	8.04e-05	0.000439	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—OXT—epilepsy syndrome	8.04e-05	0.000439	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL3—epilepsy syndrome	8.04e-05	0.000439	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ST3GAL3—epilepsy syndrome	8e-05	0.000437	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NPY2R—epilepsy syndrome	7.84e-05	0.000428	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR8—epilepsy syndrome	7.84e-05	0.000428	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ARHGEF9—epilepsy syndrome	7.84e-05	0.000428	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR9—epilepsy syndrome	7.84e-05	0.000428	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SSTR1—epilepsy syndrome	7.84e-05	0.000428	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM3—epilepsy syndrome	7.69e-05	0.00042	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM4—epilepsy syndrome	7.69e-05	0.00042	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DUSP4—epilepsy syndrome	7.54e-05	0.000412	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SSTR2—epilepsy syndrome	7.54e-05	0.000412	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCG2—epilepsy syndrome	7.29e-05	0.000398	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM8—epilepsy syndrome	7.29e-05	0.000398	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PGF—epilepsy syndrome	7.29e-05	0.000398	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—SST—epilepsy syndrome	7.27e-05	0.000397	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR2—epilepsy syndrome	7.27e-05	0.000397	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—POMC—epilepsy syndrome	7.13e-05	0.00039	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADRA2A—epilepsy syndrome	7.11e-05	0.000389	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2C19—epilepsy syndrome	7.1e-05	0.000388	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP11A1—epilepsy syndrome	7.06e-05	0.000386	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—OPRD1—epilepsy syndrome	6.95e-05	0.00038	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GNAO1—epilepsy syndrome	6.95e-05	0.00038	CbGpPWpGaD
Mimosine—SHMT1—Disease—SLC2A1—epilepsy syndrome	6.88e-05	0.000376	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—BDKRB2—epilepsy syndrome	6.83e-05	0.000374	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL12—epilepsy syndrome	6.83e-05	0.000374	CbGpPWpGaD
Mimosine—SHMT1—Disease—JUNB—epilepsy syndrome	6.83e-05	0.000373	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOS1—epilepsy syndrome	6.78e-05	0.000371	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CNR1—epilepsy syndrome	6.71e-05	0.000367	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PLCB1—epilepsy syndrome	6.68e-05	0.000365	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDYN—epilepsy syndrome	6.66e-05	0.000364	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR7—epilepsy syndrome	6.66e-05	0.000364	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM1—epilepsy syndrome	6.66e-05	0.000364	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CHRM1—epilepsy syndrome	6.66e-05	0.000364	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR7—epilepsy syndrome	6.54e-05	0.000358	CbGpPWpGaD
Mimosine—SHMT1—Disease—HBEGF—epilepsy syndrome	6.47e-05	0.000354	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2D6—epilepsy syndrome	6.37e-05	0.000348	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HBEGF—epilepsy syndrome	6.35e-05	0.000347	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT3—epilepsy syndrome	6.35e-05	0.000347	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GFAP—epilepsy syndrome	6.27e-05	0.000342	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GAL—epilepsy syndrome	6.27e-05	0.000342	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT3—epilepsy syndrome	6.24e-05	0.000341	CbGpPWpGaD
Mimosine—SHMT1—Disease—ADAM10—epilepsy syndrome	6.2e-05	0.000339	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP2—epilepsy syndrome	6.2e-05	0.000339	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CHRM3—epilepsy syndrome	6.2e-05	0.000339	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRM5—epilepsy syndrome	6.2e-05	0.000339	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ADRA2A—epilepsy syndrome	6.06e-05	0.000332	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—BCHE—epilepsy syndrome	6.04e-05	0.00033	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—AGT—epilepsy syndrome	5.96e-05	0.000326	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CX3CR1—epilepsy syndrome	5.94e-05	0.000325	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BDKRB1—epilepsy syndrome	5.82e-05	0.000318	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CHRM2—epilepsy syndrome	5.82e-05	0.000318	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CX3CL1—epilepsy syndrome	5.82e-05	0.000318	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDC42—epilepsy syndrome	5.79e-05	0.000317	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC2A1—epilepsy syndrome	5.76e-05	0.000315	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PLCB1—epilepsy syndrome	5.7e-05	0.000312	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CDC42—epilepsy syndrome	5.69e-05	0.000311	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TH—epilepsy syndrome	5.68e-05	0.00031	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GABBR1—epilepsy syndrome	5.67e-05	0.00031	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AVP—epilepsy syndrome	5.51e-05	0.000301	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRH3—epilepsy syndrome	5.43e-05	0.000297	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—OPRM1—epilepsy syndrome	5.35e-05	0.000292	CbGpPWpGaD
Mimosine—SHMT1—Disease—HES1—epilepsy syndrome	5.3e-05	0.00029	CbGpPWpGaD
Mimosine—SHMT1—Disease—FYN—epilepsy syndrome	5.16e-05	0.000282	CbGpPWpGaD
Mimosine—SHMT1—Disease—H2AFX—epilepsy syndrome	5.14e-05	0.000281	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR3—epilepsy syndrome	5.05e-05	0.000276	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—POMC—epilepsy syndrome	5.02e-05	0.000274	CbGpPWpGaD
Mimosine—SHMT1—Disease—YWHAZ—epilepsy syndrome	4.96e-05	0.000271	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NPY—epilepsy syndrome	4.92e-05	0.000269	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ATP2A2—epilepsy syndrome	4.92e-05	0.000269	CbGpPWpGaD
Mimosine—SHMT1—Disease—CCR5—epilepsy syndrome	4.77e-05	0.000261	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HSPB1—epilepsy syndrome	4.75e-05	0.00026	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL2—epilepsy syndrome	4.75e-05	0.00026	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—OXT—epilepsy syndrome	4.75e-05	0.00026	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CRH—epilepsy syndrome	4.75e-05	0.00026	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL3—epilepsy syndrome	4.75e-05	0.00026	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HMOX1—epilepsy syndrome	4.74e-05	0.000259	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR5—epilepsy syndrome	4.68e-05	0.000256	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CAT—epilepsy syndrome	4.68e-05	0.000256	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.58e-05	0.000251	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCB1—epilepsy syndrome	4.55e-05	0.000249	CbGpPWpGaD
Mimosine—SHMT1—Disease—TSC2—epilepsy syndrome	4.43e-05	0.000242	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TSC1—epilepsy syndrome	4.41e-05	0.000241	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTK2B—epilepsy syndrome	4.41e-05	0.000241	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AGT—epilepsy syndrome	4.35e-05	0.000238	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOE—epilepsy syndrome	4.34e-05	0.000237	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR2—epilepsy syndrome	4.29e-05	0.000235	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTRK2—epilepsy syndrome	4.29e-05	0.000235	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SST—epilepsy syndrome	4.29e-05	0.000235	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DUSP6—epilepsy syndrome	4.26e-05	0.000233	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GPX1—epilepsy syndrome	4.23e-05	0.000231	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.2e-05	0.00023	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLAT—epilepsy syndrome	4.18e-05	0.000229	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6ST—epilepsy syndrome	4.07e-05	0.000223	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOS2—epilepsy syndrome	4.04e-05	0.000221	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL12—epilepsy syndrome	4.04e-05	0.000221	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.04e-05	0.000221	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.02e-05	0.00022	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6ST—epilepsy syndrome	4e-05	0.000219	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CNR1—epilepsy syndrome	3.96e-05	0.000217	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JUNB—epilepsy syndrome	3.96e-05	0.000217	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLCB1—epilepsy syndrome	3.95e-05	0.000216	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR7—epilepsy syndrome	3.87e-05	0.000211	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HBEGF—epilepsy syndrome	3.75e-05	0.000205	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AGT—epilepsy syndrome	3.71e-05	0.000203	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT3—epilepsy syndrome	3.68e-05	0.000201	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—POMC—epilepsy syndrome	3.66e-05	0.0002	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOE—epilepsy syndrome	3.63e-05	0.000199	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADAM10—epilepsy syndrome	3.6e-05	0.000197	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—S100B—epilepsy syndrome	3.4e-05	0.000186	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SOCS3—epilepsy syndrome	3.37e-05	0.000184	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDC42—epilepsy syndrome	3.36e-05	0.000184	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF2—epilepsy syndrome	3.3e-05	0.00018	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AVP—epilepsy syndrome	3.25e-05	0.000178	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—POMC—epilepsy syndrome	3.12e-05	0.000171	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HES1—epilepsy syndrome	3.08e-05	0.000168	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTOR—epilepsy syndrome	3e-05	0.000164	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FYN—epilepsy syndrome	2.99e-05	0.000164	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—H2AFX—epilepsy syndrome	2.98e-05	0.000163	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MEF2C—epilepsy syndrome	2.98e-05	0.000163	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTGS2—epilepsy syndrome	2.97e-05	0.000163	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.88e-05	0.000157	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALB—epilepsy syndrome	2.85e-05	0.000156	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NGF—epilepsy syndrome	2.84e-05	0.000155	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR5—epilepsy syndrome	2.77e-05	0.000151	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HTR2A—epilepsy syndrome	2.71e-05	0.000148	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TSC2—epilepsy syndrome	2.57e-05	0.000141	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AGT—epilepsy syndrome	2.57e-05	0.00014	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOE—epilepsy syndrome	2.52e-05	0.000138	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTGS2—epilepsy syndrome	2.49e-05	0.000136	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KDR—epilepsy syndrome	2.47e-05	0.000135	CbGpPWpGaD
Mimosine—SHMT1—Disease—SRC—epilepsy syndrome	2.4e-05	0.000131	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKCB—epilepsy syndrome	2.37e-05	0.00013	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6ST—epilepsy syndrome	2.36e-05	0.000129	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—POMC—epilepsy syndrome	2.16e-05	0.000118	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF2—epilepsy syndrome	1.91e-05	0.000105	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RELA—epilepsy syndrome	1.78e-05	9.7e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-05	9.52e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-05	8.75e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JUN—epilepsy syndrome	1.56e-05	8.5e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-05	8.27e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—epilepsy syndrome	1.49e-05	8.17e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-05	8.02e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SRC—epilepsy syndrome	1.4e-05	7.63e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-05	7.43e-05	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—epilepsy syndrome	1.25e-05	6.84e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—epilepsy syndrome	8.67e-06	4.74e-05	CbGpPWpGaD
